Dni Metals Inc (DMNKD) 0.1000 $DMNKD DNI Metals Inc.,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dni Metals Inc (DMNKD) 0.1000 $DMNKD

DNI Metals Inc., Mutually Agrees to Terminate Merger Discussions with CR Capital to Pursue Other Options
ACCESSWIRE - Mon Jun 20, 4:28PM CDT
TORONTO, ON / ACCESSWIRE / June 20, 2016 / DNI Metals Inc. (CSE: DNI) (OTC: DMNKF) (FSE: DG7N) ("DNI" or the "Company" has mutually agreed to terminate merger discussions with CR Capital Corp (TSXV: CIT-H) in respect of the Non-Binding Letter of Intent signed on January 27, 2016.
CIT-H.VN: 0.060 (-0.020)

DNI Metals Inc. Appoints New Director
ACCESSWIRE - Fri Jun 03, 8:13AM CDT
TORONTO, ON / ACCESSWIRE / June 3, 2016 / DNI Metals Inc. (CSE: DNI) (OTC: DMNKF) (FSE: DG7N) ("DNI" or the "Company" DNI adds New Director, Keith Minty, a mining engineer to help with the development of the Vohitsara Graphite Deposit.

DNI Metals Inc. Appoints Lithium Ion Battery and Fuel Cell experts to the Board of Directors
GlobeNewswire - Wed May 25, 12:57PM CDT
DNI Metals Inc. (CSENI) (FrankfurtG7N) ("DNI" or the "Company" As part of the transformation that DNI Metals has achieved over the past 18 months, DNI is adding Lithium Ion Battery and Fuel Cell expertise to the board of Directors. This will help position DNI to take full advantage of the "clean technology revolution".

DNI Metals Inc. Announces Completion of $500,000.00 Financing
ACCESSWIRE - Thu May 19, 7:10AM CDT
TORONTO, ON / ACCESSWIRE / May 19, 2016 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) ("DNI" or the "Company" Further to its news release dated January 29, 2016, the Company has closed, subject to final Regulatory approval, the final tranche (the "Final Tranche" of its non-brokered private placement financing (the "Private Placement". The Final Tranche comprises 1,475,000 units of the Company (the "Units" at a price of Cdn$0.05 per Unit for aggregate gross proceeds of Cdn$73,750.00 Each Unit consists of one common share of the Company (a "Common Share" and one common share purchase warrant of the Company ("Warrant". Each Warrant will entitle the holder to acquire one additional Common Share at a price of Cdn$0.10 per Common Share for a period of 18 months following the date of the closing of the Final Tranche. All securities issued under the final Tranche are subject to a four-month hold period expiring on October 20, 2016. A finder's fee of $3,200 cash and 38,000 shares and will be paid, in conjunction with this closing. 15,744 non-transferable common share purchase warrants (the "Broker's Warrants" will also be issued and are, subject to final Regulatory approval, payable in connection with the closing of the Final Tranche. Each Broker's Warrant will be exercisable into one Common Share at an exercise price of Cdn$0.10 for a period of 18 months following issuance. This completes the $500,000.00 financing.

DNI Metals Inc. Announces Closing of Fourth Tranche of Private Placement
ACCESSWIRE - Tue Apr 19, 6:36AM CDT
TORONTO, ON / ACCESSWIRE / April 19, 2016 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) ("DNI" or the "Company" Further to its news release dated January 29, 2016, the Company has closed, subject to final Regulatory approval, the fourth tranche (the "Fourth Tranche" of its non-brokered private placement financing (the "Private Placement". The Fourth Tranche comprises 700,000 units of the Company (the "Units" at a price of Cdn$0.05 per Unit for aggregate gross proceeds of Cdn$35,000. Each Unit consists of one common share of the Company (a "Common Share" and one common share purchase warrant of the Company ("Warrant". Each Warrant will entitle the holder to acquire one additional Common Share at a price of Cdn$0.10 per Common Share for a period of 18 months following the date of the closing of the Fourth Tranche. All securities issued under the Third Tranche are subject to a four-month hold period expiring on August 19, 2016. A finder's fee of $4,400 cash will be paid, in conjunction with this closing.

DNI Metals Inc Closes Third Tranche of Private Placement
ACCESSWIRE - Fri Apr 15, 9:10AM CDT
TORONTO, ON / ACCESSWIRE / April 15, 2016 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) ("DNI" or the "Company" Further to its news release dated January 29, 2016, the Company has closed, subject to final Regulatory approval, the third tranche (the "Third Tranche" of its non-brokered private placement financing (the "Private Placement". The Third Tranche comprises 4,224,000 units of the Company (the "Units" at a price of Cdn$0.05 per Unit for aggregate gross proceeds of Cdn$211,200. Each Unit consists of one common share of the Company (a "Common Share" and one common share purchase warrant of the Company ("Warrant". Each Warrant will entitle the holder to acquire one additional Common Share at a price of Cdn$0.10 per Common Share for a period of 18 months following the date of the closing of the Third Tranche. All securities issued under the Third Tranche are subject to a four-month hold period expiring on October 15, 2016. Insiders subscribed for 38.5% of the securities in the Third Tranche of the Private Placement.

DNI Update
ACCESSWIRE - Wed Mar 30, 8:07AM CDT
TORONTO, ON / ACCESSWIRE / March 30, 2016 / DNI Metals Inc. (CSE: DNI) (FSE: DG7N) ("DNI" or the "Company" announces that, it has received 2 term sheets for funding that would form part of the $7 million funding package for DNI's 2016 business plan, that includes the development of DNI's Madagascar graphite project and the purchase of the Lab/Tech Centre announced in a press release dated Aug. 25, 2015.

DNI Metals to Host an Investor Tour and Graphite Flotation Demo
ACCESSWIRE - Fri Mar 04, 10:09AM CST
TORONTO, ON / ACCESSWIRE / March 4, 2016 / DNI METALS INC. (CSE: DNI) (FSE: DG7N PDAC)

Correction: DNI Closes First Tranche of Private Placement
ACCESSWIRE - Fri Jan 29, 7:19PM CST
TORONTO, ON / ACCESSWIRE / January 29, 2016 / DNI Metals Inc. (CSE: DNI) ("DNI" or the "Company" announces that, further to its news release dated January 29, 2016, the Company has closed, subject to final Regulatory approval, the first tranche (the "First Tranche" of its non-brokered private placement financing (the "Private Placement". The First Tranche comprises 2,000,000 units of the Company (the "Units" at a price of CDN$0.05 per Unit for aggregate gross proceeds of CDN$100,000. Each Unit consists of one common share of the Company (a "Common Share" and one common share purchase warrant of the Company ("Warrant". Each Warrant will entitle the holder to acquire one additional Common Share at a price of CDN$0.10 per Common Share for a period of 18 months following the date of the closing of the First Tranche. All securities issued under the First Tranche are subject to a four month hold period expiring on May 29th 2016. Pursuant to this placement, DNI's officers and directors subscribed for 70.5% of the securities in the first tranche of the Private Placement.

DNI Closes First Tranche of Private Placement
Newsfile Corp - Fri Jan 29, 7:06PM CST
full story)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 2

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Walmart's Options Market Trends and Insights

Updated Category News Views 131

An In-Depth Analysis of Walmart's Options Market Investors with substantial resources are currently adopting a bearish outlook on Walmart (WMT). This trend is significant for market participants to note. Observations from public options records indicate that a notable shift in sentiment has occurred recently. While the identities of these investors remain undisclosed,...

Continue Reading
Bio-Techne Announces Exciting Dividend for Shareholders

Updated Category News Views 95

Bio-Techne Announces Dividend Payment Bio-Techne Corporation (NASDAQ: TECH) has exciting news for its shareholders! The company declared a quarterly dividend of $0.08 per share for the recent quarter. This decision from the Board of Directors marks a continued commitment to returning value to its common shareholders. Overview of the Dividend The dividend will be payable...

Continue Reading
Significant Insider Trading Alert: Century Aluminum's SVP Action

Updated Category News Views 142

Recent Insider Trading Activity at Century Aluminum Notable insider trading activity was reported recently surrounding Century Aluminum involving their Senior Vice President, Matt Aboud. The SEC filings revealed that Aboud sold an impressive 12,027 shares of the company. The total value of this transaction amounted to approximately $279,868. Market Response and Share...

Continue Reading
Winning Moment for Travel Nurse in National Healthcare Contest

Updated Category News Views 210

Celebrating the Triumph of Travel Nurse Amber Ellis In an inspiring event highlighting the dedication of healthcare professionals, Amber Ellis, a travel nurse, emerged as the grand prize winner of a remarkable $60,000 giveaway organized by Medical Solutions. This exciting announcement emphasizes the importance of recognizing frontline workers and their pivotal role in...

Continue Reading
Unveiling Opportunities in Land Investment and Development

Updated Category News Views 246

Understanding Land Investment and Its Potential Land investment has emerged as a pivotal subject in today's ever-evolving economic landscape. As urban spaces expand and the demand for sustainable living increases, understanding the art and science of land investment is more crucial than ever. Jose M. Berlanga's insightful book examines how land serves as the foundation of...

Continue Reading